Clonal hematopoiesis is associated with risk of severe Covid-19

Kelly L Bolton1, Youngil Koh2,3,4, Michael B Foote5

  • 1Department of Medicine, Washington University, St Louis, MO, USA. bolton@wustl.edu.

Nature Communications
|October 14, 2021
PubMed

Insights

Clonal hematopoiesis (CH) is linked to severe COVID-19 and increased risk of bacterial infections like C. difficile. This suggests CH may predispose individuals to serious infections, warranting further study.

Area of Science:

  • Hematology
  • Immunology
  • Infectious Diseases

Background:

  • Clonal hematopoiesis (CH) involves acquired somatic mutations in hematopoietic stem cells, increasing risks for cardiovascular and malignant diseases.
  • CH is associated with altered inflammatory profiles, which can worsen outcomes in infections like COVID-19.

Purpose of the Study:

  • To investigate whether CH predisposes individuals to severe COVID-19.
  • To examine the association between CH and the risk of other infections in patients with solid tumors.

Main Methods:

  • Analysis of 525 individuals with COVID-19 from the Memorial Sloan Kettering (MSK) and Korean Clonal Hematopoiesis (KoCH) consortia.
  • Examination of infection risk in 14,211 solid tumor patients at MSK with identified CH.

Main Results:

  • CH was associated with severe COVID-19 outcomes (OR=1.85, p=0.01), particularly CH with non-cancer driver mutations (OR=2.01, p=0.01).
  • CH significantly correlated with increased risk of Clostridium difficile (HR=2.01, p=6x10^-3) and Streptococcus/Enterococcus infections (HR=1.56, p=5x10^-3) in solid tumor patients.

Conclusions:

  • CH is associated with severe COVID-19.
  • CH is linked to an elevated risk of specific bacterial infections, suggesting a broader role in infection susceptibility.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
9.4K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.9K